Lian Mao

1.2k total citations
32 papers, 973 citations indexed

About

Lian Mao is a scholar working on Psychiatry and Mental health, Philosophy and Pathology and Forensic Medicine. According to data from OpenAlex, Lian Mao has authored 32 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Psychiatry and Mental health, 8 papers in Philosophy and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Lian Mao's work include Schizophrenia research and treatment (20 papers), Migraine and Headache Studies (8 papers) and Mental Health and Psychiatry (8 papers). Lian Mao is often cited by papers focused on Schizophrenia research and treatment (20 papers), Migraine and Headache Studies (8 papers) and Mental Health and Psychiatry (8 papers). Lian Mao collaborates with scholars based in United States, Spain and Switzerland. Lian Mao's co-authors include Larry Alphs, H. Lynn Starr, Georges M. Gharabawi, Steven J. Greenberg, Gary Finlayson, Carmela Benson, Philip D. Harvey, Roger Cady, Chris M Kozma and Concetta Crivera and has published in prestigious journals such as Epilepsia, Schizophrenia Research and The Journal of Clinical Psychiatry.

In The Last Decade

Lian Mao

32 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lian Mao United States	22	826	202	174	138	135	32	973
Holland C. Detke United States	20	1.6k 2.0×	559 2.8×	316 1.8×	331 2.4×	151 1.1×	59	1.8k
Jamie Kane United States	6	887 1.1×	57 0.3×	66 0.4×	284 2.1×	281 2.1×	13	1.2k
W. W. Fleischhacker Austria	19	861 1.0×	38 0.2×	147 0.8×	211 1.5×	184 1.4×	53	1.5k
Weiping Yu Netherlands	8	1.2k 1.5×	18 0.1×	467 2.7×	179 1.3×	98 0.7×	11	1.8k
Isabel Monteiro United States	13	766 0.9×	23 0.1×	259 1.5×	134 1.0×	54 0.4×	30	1.1k
Jonathan G. Leung United States	15	339 0.4×	39 0.2×	86 0.5×	78 0.6×	36 0.3×	92	1.0k
Benchalak Maneeton Thailand	20	477 0.6×	35 0.2×	37 0.2×	212 1.5×	40 0.3×	66	1.1k
Manfred Beneke Germany	18	681 0.8×	46 0.2×	52 0.3×	180 1.3×	17 0.1×	34	992
Anita S. Kablinger United States	14	216 0.3×	40 0.2×	77 0.4×	133 1.0×	44 0.3×	50	641
D Van Eyck Belgium	16	1.1k 1.3×	13 0.1×	371 2.1×	86 0.6×	71 0.5×	33	1.4k

Countries citing papers authored by Lian Mao

Since Specialization

Citations

This map shows the geographic impact of Lian Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian Mao more than expected).

Fields of papers citing papers by Lian Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lian Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian Mao. The network helps show where Lian Mao may publish in the future.

Co-authorship network of co-authors of Lian Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Lian Mao. A scholar is included among the top collaborators of Lian Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lian Mao. Lian Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joshi, Kruti, et al.. (2018). The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia. BMC Psychiatry. 18(1). 24–24. 7 indexed citations

Starr, H. Lynn, et al.. (2017). Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: An exploratory analysis of the PRIDE study. Schizophrenia Research. 194. 39–46. 28 indexed citations

Kim, Edward, Christoph U. Correll, Lian Mao, H. Lynn Starr, & Larry Alphs. (2016). Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia. CNS Spectrums. 21(6). 466–477. 15 indexed citations

Muser, Erik, Chris M Kozma, Carmela Benson, et al.. (2015). Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement. Journal of Medical Economics. 18(8). 637–645. 7 indexed citations

Alphs, Larry, Lian Mao, H. Lynn Starr, & Carmela Benson. (2015). A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia. Schizophrenia Research. 170(2-3). 259–264. 27 indexed citations

Alphs, Larry, et al.. (2014). Design and Rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) Study. The Journal of Clinical Psychiatry. 75(12). 1388–1393. 23 indexed citations

Macfadden, Wayne, Cherilyn DeSouza, Concetta Crivera, et al.. (2011). Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results. BMC Psychiatry. 11(1). 167–167. 27 indexed citations

Crivera, Concetta, Cherilyn DeSouza, Chris M Kozma, et al.. (2011). Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE). BMC Psychiatry. 11(1). 168–168. 26 indexed citations

Kozma, Chris M, et al.. (2010). Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension. Annals of General Psychiatry. 9(1). 24–24. 23 indexed citations

10.

Cady, Roger, Frederick G. Freitag, Ninan T. Mathew, et al.. (2009). Allodynia‐Associated Symptoms, Pain Intensity and Time to Treatment: Predicting Treatment Response in Acute Migraine Intervention. Headache The Journal of Head and Face Pain. 49(3). 350–363. 23 indexed citations

11.

Diamond, Merle L., Roger Cady, Lian Mao, et al.. (2008). Characteristics of Migraine Attacks and Responses to Almotriptan Treatment: A Comparison of Menstrually Related and Nonmenstrually Related Migraines. Headache The Journal of Head and Face Pain. 48(2). 248–258. 50 indexed citations

12.

Janicak, Philip G., et al.. (2008). Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials. Current Medical Research and Opinion. 24(6). 1807–1815. 8 indexed citations

13.

Adelman, James U., Fred Freitag, Miguel J. A. Láinez, et al.. (2008). Analysis of Safety and Tolerability Data Obtained from Over 1,500 Patients Receiving Topiramate for Migraine Prevention in Controlled Trials. Pain Medicine. 9(2). 175–185. 40 indexed citations

14.

Freitag, Frederick G., Timothy R. Smith, Ninan T. Mathew, et al.. (2008). Effect of Early Intervention With Almotriptan vs Placebo on Migraine‐Associated Functional Disability: Results From the AEGIS Trial. Headache The Journal of Head and Face Pain. 48(3). 341–354. 24 indexed citations

15.

Dahlöf, Carl, Elizabeth Loder, Merle L. Diamond, et al.. (2007). The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health and Quality of Life Outcomes. 5(1). 56–56. 35 indexed citations

16.

Harvey, Philip D., et al.. (2007). Cognitive Functioning and Acute Sedative Effects of Risperidone and Quetiapine in Patients With Stable Bipolar I Disorder. The Journal of Clinical Psychiatry. 68(8). 1186–1194. 42 indexed citations

17.

Mathew, Ninan T., Gary Finlayson, Timothy R. Smith, et al.. (2007). Early Intervention With Almotriptan: Results of the AEGIS Trial (AXERT ^® Early Migraine Intervention Study). Headache The Journal of Head and Face Pain. 47(2). 189–198. 56 indexed citations

18.

Kahrilas, Peter J., Philip B. Miner, John F. Johanson, et al.. (2005). Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease. Digestive Diseases and Sciences. 50(11). 2009–2018. 37 indexed citations

19.

Gharabawi, Georges M., Cynthia A. Bossie, Young Zhu, Lian Mao, & Robert Lasser. (2005). An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: Results from a long-term study. Schizophrenia Research. 77(2-3). 129–139. 33 indexed citations

20.

Lasser, Robert, Lian Mao, & Georges M. Gharabawi. (2003). Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications. Schizophrenia Research. 66(2-3). 163–167. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact